山东铂源药业股份有限公司
Shandong Boyuan Pharmaceutical Co. Ltd. Jinan City Cn
Country: CN CDE+CEP MEDIUM
🇨🇳 CDE
21
21 products shown
🇺🇸 DMF
0
0 products shown
🇪🇺 CEP
5
5 products shown
Total
26
registrations
🇨🇳 CDE 注册 (21)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Capecitabine 卡培他滨 | 154361-50-9 | Class A | Y20170000785 |
| Carboplatin 卡铂 | 41575-94-4 | Class A | Y20230001293 |
| Cisatracurium Besilate 苯磺顺阿曲库铵 | 96946-41-7 | Class A | Y20240000828 |
| Cisplatin 顺铂 | 15663-27-1 | Class A | Y20240000430 |
| Crisaborole 克立硼罗 | 906673-24-3 | Class I | Y20250001376 |
| Empagliflozin 恩格列净 | 864070-44-0 | Class I | Y20240001013 |
| Enzalutamide 氘恩扎鲁胺 | 915087-33-1 | Class I | Y20240001021 |
| Ezetimibe 依折麦布 | 163222-33-1 | Class A | Y20200001270 |
| Febuxostat 非布司他 | 144060-53-7 | Class A | Y20190021233 |
| Ifosfamide 异环磷酰胺 | 3778-73-2 | Class I | Y20260000099 |
| Lapatinib 甲苯磺酸拉帕替尼 | 388082-78-8 | Class I | Y20250000676 |
| Mitiglinide Calcium 米格列奈钙 | 145375-43-5 | Class A | Y20170001146 |
| Oxaliplatin 奥沙利铂 | 61825-94-3 | Class A | Y20170000383 |
| Palbociclib 帕博西尼 | 571190-30-2 | Class I | Y20240000829 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20230001379 |
| Rivaroxaban 利伐沙班 | 366789-02-8 | Class A | Y20240001064 |
| Ropivacaine 盐酸罗哌卡因 | 84057-95-4 | Class I | Y20250000667 |
| Ropivacaine Hydrochloride 罗哌卡因 | 84057-95-4 | Class I | Y20250000815 |
| Terbinafine 盐酸特比萘芬 | 91161-71-6 | Class I | Y20240000787 |
| Terbinafine 盐酸特比萘芬 | 91161-71-6 | Class A | Y20190006036 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class I | Y20240001140 |
🇪🇺 CEP 注册 (5)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Capecitabine 卡培他滨 | 154361-50-9 | R1-CEP 2014-343 - Rev 01 | - |
| Oxaliplatin 奥沙利铂 | 61825-94-3 | CEP 2013-113 - Rev 01 | - |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | CEP 2015-217 - Rev 01 | - |
| Racecadotril 消旋卡多曲 | 81110-73-8 | CEP 2016-179 - Rev 01 | - |
| Terbinafine Hydrochloride 盐酸特比萘芬 | 78628-80-5 | CEP 2024-205 - Rev 00 | - |
Source: ema_cep;FDA_DMF | Updated: 2026-04-09 07:23:02